Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year

The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.

[...]

US FDA Joins Interpol and Other International Enforcement Agencies for Operation Pangea XI

The United States Food and Drug Administration (FDA) has announced the conclusion of Operation Pangea XI’s International Week of Action. In its eleventh year, Operation Pangea targets websites that sell counterfeit and misbranded drugs. This year’s effort shut down 465 websites that were selling non-FDA approved prescription drugs including drugs for oncology, antivirals, opioids and other untested prescription drugs to U.S. consumers.

[...]

More Warning Letters Sent By FDA to Websites Selling Illicit Opioids Online

For the second time since May, the U.S. Food and Drug Administration (FDA) announced issuing warning letters to online network operations that were marketing illicit opioids to American citizens. In this most recent group, four companies operating a total of 21 websites were told they needed stop selling those pills. The number of websites to receive warnings this summer is over 70…

[...]

FL Company Ordered To Stop Selling Adulterated And Misbranded Drugs

The U.S. DOJ received a permanent injunction against MyNicNaxs, a company based in Deltona, Florida, for the sale and distribution of unapproved and misbranded new drugs. Despite receiving a warning letter in 2013, the company continued to sell dietary supplements that contained undisclosed pharmaceutical ingredients…

[...]